What are the major opportunities in the Opioid-Induced Constipation Treatment market? What are the strategies for the Opioid-Induced Constipation Treatment market?

For detailed insights on the major opportunities and strategies in the Opioid-Induced Constipation Treatment market, Read More

How does the Opioid-Induced Constipation Treatment market relate to the overall economy and other similar markets?

For detailed insights on Opioid-Induced Constipation Treatment's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Opioid-Induced Constipation Treatment market growth? SWOT analysis of the Opioid-Induced Constipation Treatment market.

For detailed insights on the key dynamics influencing the Opioid-Induced Constipation Treatment market growth and SWOT analysis of the Opioid-Induced Constipation Treatment industry, Read More

Opioid-Induced Constipation Treatment Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Opioid-Induced Constipation Treatment Market Report 2026

Name: Opioid-Induced Constipation Treatment Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug Class (Laxatives, Peripherally Acting µ-opioid Receptor Antagonists, Serotonin Receptor Agonists), By Type (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Opioid-Induced Constipation Treatment Market Overview

• Opioid-Induced Constipation Treatment market size has reached to $1.9 billion in 2025

• Expected to grow to $2.54 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%

• Growth Driver: Rising Opioid Use For Pain Management Fuels Growth In Opioid-Induced Constipation Treatment Market

• Market Trend: Adoption Of Mechanism-Targeted Therapies In Opioid-Induced Constipation (OIC) Treatment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Opioid-Induced Constipation Treatment Market?

Opioid-induced constipation (OIC) treatment refers to the various approaches and medications used to manage constipation caused by the use of opioid medications. These treatments aim to alleviate the symptoms of constipation without compromising the pain-relieving effects of opioids, thereby improving the patient's overall quality of life and maintaining effective pain management with both pharmacological with non-pharmacological approaches.

The drug classes of opioid-induced constipation treatment include laxatives, peripherally acting mu-opioid receptor antagonists, serotonin receptor agonists, and prostaglandin. Laxatives are medications used to promote bowel movements and relieve constipation by increasing stool frequency and softening stool consistency. They can be administered through various types or routes including oral and parenteral including subcutaneous injection and distributed through hospital pharmacies, online pharmacies, and retail pharmacies.

Opioid-Induced Constipation Treatment Market Global Report 2026 Market Report bar graph

What Is The Opioid-Induced Constipation Treatment Market Size and Share 2026?

The opioid-induced constipation treatment market size has grown strongly in recent years. It will grow from $1.9 billion in 2025 to $2.02 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to widespread opioid use for chronic pain management, limited effectiveness of traditional laxatives, growing prevalence of cancer-related pain, lack of early OIC-specific therapies, increasing hospitalization due to opioid side effects.

What Is The Opioid-Induced Constipation Treatment Market Growth Forecast?

The opioid-induced constipation treatment market size is expected to see strong growth in the next few years. It will grow to $2.54 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to rising demand for PAMORA-based therapies, increasing long-term opioid prescriptions in aging populations, growing clinical focus on patient-centric pain management, expansion of online and retail pharmacy access, increasing investment in gastrointestinal disorder drug development. Major trends in the forecast period include rising adoption of peripherally acting µ-opioid receptor antagonists, increasing preference for targeted OIC therapies without affecting analgesia, growing use of combination pharmacological and non-pharmacological treatments, rising focus on improving quality of life in chronic pain patients, increasing awareness and diagnosis of opioid-induced constipation.

Book your 30 minutes free consultation with our research experts

Global Opioid-Induced Constipation Treatment Market Segmentation

1) By Drug Class: Laxatives, Peripherally Acting µ-opioid Receptor Antagonists, Serotonin Receptor Agonists

2) By Type: Oral, Parenteral

3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

Subsegments:

1) By Laxatives: Osmotic Laxatives, Stimulant Laxatives, Bulk-Forming Laxatives

2) By Peripherally Acting µ-Opioid Receptor Antagonists: Naloxegol, Methylnaltrexone, Alvimopan

3) By Serotonin Receptor Agonists: Prucalopride, Tegaserod

What Is The Driver Of The Opioid-Induced Constipation Treatment Market?

The rise in the administration of opioids for cancer and non-cancer pain is expected to propel the growth of the opioid-induced constipation treatment market going forward. Cancer pain refers to pain associated with cancer and its treatment, while non-cancer pain refers to pain from conditions unrelated to cancer. Administration of opioids for cancer and non-cancer pain is driven by the need to effectively manage moderate to severe pain, considering factors such as the intensity and duration of pain, patient response to other treatments, and the overall goal of improving quality of life while minimizing potential risks of addiction and side effects. Opioid-induced constipation (OIC) treatment helps patients with cancer and non-cancer pain by relieving constipation caused by opioid use, thereby improving overall comfort, adherence to pain management regimens, and quality of life without compromising pain relief. For instance, in November 2024, according to the Centers for Disease Control and Prevention, a US-based public health agency, in 2023, rate of 37.5 opioid prescriptions dispensed per 100 persons. Further, states with the highest opioid dispensing rates per 100 persons in 2023 include Arkansas (71.5), Alabama (71.4), Mississippi (63.1), and Louisiana (62.7). Therefore, the rise in the administration of opioids for cancer and non-cancer pain is driving the growth of the opioid-induced constipation treatment industry.

Key Players In The Global Opioid-Induced Constipation Treatment Market

Major companies operating in the opioid-induced constipation treatment market are Pfizer Inc., AstraZeneca plc, Takeda Pharmaceutical Company Limited, Bausch Health Companies Inc., Ironwood Pharmaceuticals Inc., Collegium Pharmaceutical Inc., Cumberland Pharmaceuticals Inc., RedHill Biopharma Ltd., Theravance Biopharma Inc., Mundipharma International Limited, Daiichi Sankyo Co Ltd, Progenics Pharmaceuticals Inc, Shionogi & Co Ltd, Purdue Pharma, Nektar Therapeutics, S L A Pharma AG, Bristol-Myers Squibb Company, Fresenius Kabi AG, Viatris Inc, Novartis AG, Teva Pharmaceutical Industries Ltd, F Hoffmann-La Roche Ltd, Aurobindo Pharma, Abbott Laboratories, Daewoong Pharmaceutical Company

Global Opioid-Induced Constipation Treatment Market Trends and Insights

Major companies are operating in the opioid-induced constipation treatment market focusing on developing innovation such as peripherally acting µ-opioid receptor antagonists (PAMORAs) for targeted gut receptor modulation to enhance efficacy, improve patient compliance, and reduce systemic side effects during opioid therapy. A PAMORA selectively blocks µ-opioid receptors in the gastrointestinal tract without crossing the blood–brain barrier, thereby restoring bowel function while maintaining central analgesia unlike traditional laxatives, which do not address the underlying receptor-mediated cause of constipation. For instance, in May 2025, Luye Pharma, a China-based pharmaceutical company, launched Mimeixin, an oral oxycodone/naloxone sustained-release tablet designed for OIC. The product delivers once-daily analgesia while antagonizing gut opioid receptors, offering improved bowel regularity and reduced gastrointestinal side effects compared to older therapies, and provides a patient-friendly alternative that combines pain control and constipation management in a single tablet.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Opioid-Induced Constipation Treatment Market?

In August 2023, Grünenthal GmbH, a Germany-based pharmaceutical company completed a joint venture collaboration with Kyowa Kirin International. This collaboration includes a portfolio of 13 brands across six therapeutic areas, with a primary focus on pain management, including medications for breakthrough cancer pain, opioid-induced constipation, and osteoporosis. Grünenthal owns a 51% majority share in the joint venture collaboration, while Kyowa Kirin owns a 49% share. Grünenthal intends to acquire the remaining 49% share at the beginning of 2026. Kyowa Kirin International is a Japan-based pharmaceutical company developing medication for opioid-induced constipation including peripherally acting mu-opioid receptor antagonists.

Regional Outlook

North America was the largest region in the opioid-induced constipation treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Opioid-Induced Constipation Treatment Market?

The opioid-induced constipation treatment market includes revenues earned by entities by providing services such as medical consultation, dietary and lifestyle counselling, diagnostic and telehealth services. The market value includes the value of related goods sold by the service provider or included within the service offering. The opioid-induced constipation treatment market also includes sales of tablets, injections, syrups, fibre supplements, lubricants, enemas, suppositories and probiotics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Opioid-Induced Constipation Treatment Market Report 2026?

The opioid-induced constipation treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the opioid-induced constipation treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Opioid-Induced Constipation Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$2.02 billion
Revenue Forecast In 2035	$2.54 billion
Growth Rate	CAGR of 6.7% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug Class, Type, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., AstraZeneca plc, Takeda Pharmaceutical Company Limited, Bausch Health Companies Inc., Ironwood Pharmaceuticals Inc., Collegium Pharmaceutical Inc., Cumberland Pharmaceuticals Inc., RedHill Biopharma Ltd., Theravance Biopharma Inc., Mundipharma International Limited, Daiichi Sankyo Co Ltd, Progenics Pharmaceuticals Inc, Shionogi & Co Ltd, Purdue Pharma, Nektar Therapeutics, S L A Pharma AG, Bristol-Myers Squibb Company, Fresenius Kabi AG, Viatris Inc, Novartis AG, Teva Pharmaceutical Industries Ltd, F Hoffmann-La Roche Ltd, Aurobindo Pharma, Abbott Laboratories, Daewoong Pharmaceutical Company
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Opioid-Induced Constipation Treatment Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Opioid-Induced Constipation Treatment Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Opioid-Induced Constipation Treatment Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Opioid-Induced Constipation Treatment Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Rising Adoption Of Peripherally Acting ?-Opioid Receptor Antagonists

4.2.2 Increasing Preference For Targeted Oic Therapies Without Affecting Analgesia

4.2.3 Growing Use Of Combination Pharmacological And Non-Pharmacological Treatments

4.2.4 Rising Focus On Improving Quality Of Life In Chronic Pain Patients

4.2.5 Increasing Awareness And Diagnosis Of Opioid-Induced Constipation

5. Opioid-Induced Constipation Treatment Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Pain Management Clinics

5.3 Cancer Treatment Centers

5.4 Long-Term Care Facilities

5.5 Specialty Gastroenterology Clinics

6. Opioid-Induced Constipation Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Opioid-Induced Constipation Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Opioid-Induced Constipation Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Opioid-Induced Constipation Treatment Market Size, Comparisons And Growth Rate Analysis

7.3. Global Opioid-Induced Constipation Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Opioid-Induced Constipation Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Opioid-Induced Constipation Treatment Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Opioid-Induced Constipation Treatment Market Segmentation

9.1. Global Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Laxatives, Peripherally Acting µ-Opioid Receptor Antagonists, Serotonin Receptor Agonists

9.2. Global Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Parenteral

9.3. Global Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

9.4. Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Osmotic Laxatives, Stimulant Laxatives, Bulk-Forming Laxatives

9.5. Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Peripherally Acting µ-Opioid Receptor Antagonists, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Naloxegol, Methylnaltrexone, Alvimopan

9.6. Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Serotonin Receptor Agonists, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prucalopride, Tegaserod

10. Opioid-Induced Constipation Treatment Market Regional And Country Analysis

10.1. Global Opioid-Induced Constipation Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Opioid-Induced Constipation Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Opioid-Induced Constipation Treatment Market

11.1. Asia-Pacific Opioid-Induced Constipation Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Opioid-Induced Constipation Treatment Market

12.1. China Opioid-Induced Constipation Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Opioid-Induced Constipation Treatment Market

13.1. India Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Opioid-Induced Constipation Treatment Market

14.1. Japan Opioid-Induced Constipation Treatment Market Overview

14.2. Japan Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Opioid-Induced Constipation Treatment Market

15.1. Australia Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Opioid-Induced Constipation Treatment Market

16.1. Indonesia Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Opioid-Induced Constipation Treatment Market

17.1. South Korea Opioid-Induced Constipation Treatment Market Overview

17.2. South Korea Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Opioid-Induced Constipation Treatment Market

18.1. Taiwan Opioid-Induced Constipation Treatment Market Overview

18.2. Taiwan Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Opioid-Induced Constipation Treatment Market

19.1. South East Asia Opioid-Induced Constipation Treatment Market Overview

19.2. South East Asia Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Opioid-Induced Constipation Treatment Market

20.1. Western Europe Opioid-Induced Constipation Treatment Market Overview

20.2. Western Europe Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Opioid-Induced Constipation Treatment Market

21.1. UK Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Opioid-Induced Constipation Treatment Market

22.1. Germany Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Opioid-Induced Constipation Treatment Market

23.1. France Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Opioid-Induced Constipation Treatment Market

24.1. Italy Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Opioid-Induced Constipation Treatment Market

25.1. Spain Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Opioid-Induced Constipation Treatment Market

26.1. Eastern Europe Opioid-Induced Constipation Treatment Market Overview

26.2. Eastern Europe Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Opioid-Induced Constipation Treatment Market

27.1. Russia Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Opioid-Induced Constipation Treatment Market

28.1. North America Opioid-Induced Constipation Treatment Market Overview

28.2. North America Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Opioid-Induced Constipation Treatment Market

29.1. USA Opioid-Induced Constipation Treatment Market Overview

29.2. USA Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Opioid-Induced Constipation Treatment Market

30.1. Canada Opioid-Induced Constipation Treatment Market Overview

30.2. Canada Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Opioid-Induced Constipation Treatment Market

31.1. South America Opioid-Induced Constipation Treatment Market Overview

31.2. South America Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Opioid-Induced Constipation Treatment Market

32.1. Brazil Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Opioid-Induced Constipation Treatment Market

33.1. Middle East Opioid-Induced Constipation Treatment Market Overview

33.2. Middle East Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Opioid-Induced Constipation Treatment Market

34.1. Africa Opioid-Induced Constipation Treatment Market Overview

34.2. Africa Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Segmentation By Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Opioid-Induced Constipation Treatment Market Regulatory and Investment Landscape

36. Opioid-Induced Constipation Treatment Market Competitive Landscape And Company Profiles

36.1. Opioid-Induced Constipation Treatment Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Opioid-Induced Constipation Treatment Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Opioid-Induced Constipation Treatment Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Ironwood Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Opioid-Induced Constipation Treatment Market Other Major And Innovative Companies

Collegium Pharmaceutical Inc., Cumberland Pharmaceuticals Inc., RedHill Biopharma Ltd., Theravance Biopharma Inc., Mundipharma International Limited, Daiichi Sankyo Co Ltd, Progenics Pharmaceuticals Inc, Shionogi & Co Ltd, Purdue Pharma, Nektar Therapeutics, S L A Pharma AG, Bristol-Myers Squibb Company, Fresenius Kabi AG, Viatris Inc, Novartis AG

38. Global Opioid-Induced Constipation Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Opioid-Induced Constipation Treatment Market

40. Opioid-Induced Constipation Treatment Market High Potential Countries, Segments and Strategies

40.1 Opioid-Induced Constipation Treatment Market In 2030 - Countries Offering Most New Opportunities

40.2 Opioid-Induced Constipation Treatment Market In 2030 - Segments Offering Most New Opportunities

40.3 Opioid-Induced Constipation Treatment Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Opioid-Induced Constipation Treatment Market, Overview Of Key Products - Product Examples

Table 2: Global Opioid-Induced Constipation Treatment Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Opioid-Induced Constipation Treatment Market, Supply Chain Analysis

Table 4: Global Opioid-Induced Constipation Treatment Market, Major Raw Material Providers

Table 5: Global Opioid-Induced Constipation Treatment Market, Major Resource Providers

Table 6: Global Opioid-Induced Constipation Treatment Market, Major Manufacturers (Suppliers)

Table 7: Global Opioid-Induced Constipation Treatment Market, Major Distributors And Channel Partners

Table 8: Global Opioid-Induced Constipation Treatment Market, Key Technologies & Future Trends

Table 9: Global Opioid-Induced Constipation Treatment Market, Major Trends

Table 10: Global Opioid-Induced Constipation Treatment Market, Major End Users

Table 11: Global Opioid-Induced Constipation Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Opioid-Induced Constipation Treatment Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Opioid-Induced Constipation Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Opioid-Induced Constipation Treatment Market - TAM, US$ Billion, 2025

Table 15: Global Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Peripherally Acting µ-Opioid Receptor Antagonists, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Serotonin Receptor Agonists, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Opioid-Induced Constipation Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Opioid-Induced Constipation Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global Opioid-Induced Constipation Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global Opioid-Induced Constipation Treatment Market - Company Scoring Matrix

Table 97: Pfizer Inc. Financial Performance

Table 98: AstraZeneca plc Financial Performance

Table 99: Takeda Pharmaceutical Company Limited Financial Performance

Table 100: Bausch Health Companies Inc. Financial Performance

Table 101: Ironwood Pharmaceuticals Inc. Financial Performance

Table 102: Global Opioid-Induced Constipation Treatment Market, Competitive Benchmarking (In USD Billions)

Table 103: Global Opioid-Induced Constipation Treatment Market, Competitive Dashboard

Table 104: Global Opioid-Induced Constipation Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 105: Global, Opioid-Induced Constipation Treatment Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Table 106: Global, Opioid-Induced Constipation Treatment Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 107: Global, Opioid-Induced Constipation Treatment Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Opioid-Induced Constipation Treatment Market, Overview Of Key Products - Product Examples

Figure 2: Global Opioid-Induced Constipation Treatment Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Opioid-Induced Constipation Treatment Market, Supply Chain Analysis

Figure 4: Global Opioid-Induced Constipation Treatment Market, Major Raw Material Providers

Figure 5: Global Opioid-Induced Constipation Treatment Market, Major Resource Providers

Figure 6: Global Opioid-Induced Constipation Treatment Market, Major Manufacturers (Suppliers)

Figure 7: Global Opioid-Induced Constipation Treatment Market, Major Distributors And Channel Partners

Figure 8: Global Opioid-Induced Constipation Treatment Market, Key Technologies & Future Trends

Figure 9: Global Opioid-Induced Constipation Treatment Market, Major Trends

Figure 10: Global Opioid-Induced Constipation Treatment Market, Major End Users

Figure 11: Global Opioid-Induced Constipation Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Opioid-Induced Constipation Treatment Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Opioid-Induced Constipation Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Opioid-Induced Constipation Treatment Market - TAM, US$ Billion, 2025

Figure 15: Global Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Peripherally Acting µ-Opioid Receptor Antagonists, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Serotonin Receptor Agonists, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Opioid-Induced Constipation Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Opioid-Induced Constipation Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global Opioid-Induced Constipation Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global Opioid-Induced Constipation Treatment Market - Company Scoring Matrix

Figure 97: Pfizer Inc. Financial Performance

Figure 98: AstraZeneca plc Financial Performance

Figure 99: Takeda Pharmaceutical Company Limited Financial Performance

Figure 100: Bausch Health Companies Inc. Financial Performance

Figure 101: Ironwood Pharmaceuticals Inc. Financial Performance

Figure 102: Global Opioid-Induced Constipation Treatment Market, Competitive Benchmarking (In USD Billions)

Figure 103: Global Opioid-Induced Constipation Treatment Market, Competitive Dashboard

Figure 104: Global Opioid-Induced Constipation Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 105: Global, Opioid-Induced Constipation Treatment Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Figure 106: Global, Opioid-Induced Constipation Treatment Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 107: Global, Opioid-Induced Constipation Treatment Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Outpatient Home Therapy Industry Poised for Rapid Expansion, Projected to Hit $72.97 Billion by 2029

In-Depth Outpatient Oncology Infusion Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving Outpatient Rehabilitation Services Market

Emerging Trends and Growth Drivers in the Pediatric Dental Market Through 2029

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Corporate Identity Design Market Report 2026 - Global Outlook – By Type (Logo Design, Identity Design, Brand Design), By Company Size (Small And Medium Enterprises, Large Enterprises), By Application (Business, Governmen...

Air Management System Market Report 2026 - Global Outlook – By System (Thermal Management System, Engine Bleed Air System, Oxygen Systems, Fuel Tank Inerting Systems, Cabin Pressure Control System, Ice Protection System)...

Provider Lifecycle Management Market Report 2026 - Global Outlook – By Solutions (Recruitment, Credentialing, Online Application, Contracting, Data Management, Finder Services), By Deployment (On-Premises, Cloud-Based), ...

Web Content Management Market Report 2026 - Global Outlook – By Component (Solutions, Service), By Organization Size (Large Enterprises, Small And Medium-Sized Enterprises (SMES)), By Deployment Mode (On-Premises, Cloud)...

Laryngeal Cancer Therapeutics Market Report 2026 - Global Outlook – By Treatment Type (Chemotherapy, Immunotherapy, Other Treatments), By Route Of Administration (Oral, Parenteral), By Distribution Channel (Hospital Phar...

Composites Repair And Rehab Market Report 2026 - Global Outlook – By Product (Glass Fiber Composites, Carbon Fiber Composites, Other Products), By Process (Hand Lay-up, Vacuum Infusion, Other Processes), By Application (...

Teleradiology Market Report 2026 - Global Outlook – By Modality (X-Ray, Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Ultrasound Systems), By Technology (Web Based, Cloud Based), By Component (Hardware...

Frequently Asked Questions

How big is the Opioid-Induced Constipation Treatment Market?

The Opioid-Induced Constipation Treatment market was valued at $1.9 billion in 2025, increased to $2.02 billion in 2026, and is projected to reach $2.54 billion by 2030.

What is the Opioid-Induced Constipation Treatment market growth?

The global Opioid-Induced Constipation Treatment market is expected to grow at a CAGR of 5.9% from 2026 to 2035 to reach $2.54 billion by 2035.

Who are the key players in Opioid-Induced Constipation Treatment market?

Some Key Players in the Opioid-Induced Constipation Treatment market Include, Pfizer Inc., AstraZeneca plc, Takeda Pharmaceutical Company Limited, Bausch Health Companies Inc., Ironwood Pharmaceuticals Inc., Collegium Pharmaceutical Inc., Cumberland P

Major trend in this market includes: Adoption Of Mechanism-Targeted Therapies In Opioid-Induced Constipation (OIC) Treatment. For further insights on this market. request a sample here

North America was the largest region in the opioid-induced constipation treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the opioid-induced constipation treatm

Book your 30 minutes free consultation with our research experts

Contact Us